Difference between revisions of "Team:DTU-Denmark/Project/Overview"
| Line 37: | Line 37: | ||
<i class="fa fa-bars"></i> | <i class="fa fa-bars"></i> | ||
</button> | </button> | ||
| − | <a class="navbar-brand navimg" href="#"><img src="https:// | + | <a class="navbar-brand navimg" href="#"><img src="https://static.igem.org/mediawiki/2015/b/b7/DTU-Denmark_dtulogo.png"></a> |
</div> | </div> | ||
<!-- Collect the nav links, forms, and other content for toggling --> | <!-- Collect the nav links, forms, and other content for toggling --> | ||
| Line 194: | Line 194: | ||
<li class="hidden-lg"> | <li class="hidden-lg"> | ||
<a href="https://igem.org" target="_blank" class="navimg"> | <a href="https://igem.org" target="_blank" class="navimg"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/a/af/DTU-Denmark_igemlogo.png"> |
</a> | </a> | ||
</li> | </li> | ||
| Line 203: | Line 203: | ||
| − | <div class="jumbotron hero" style="background-image: url(https:// | + | <div class="jumbotron hero" style="background-image: url(https://static.igem.org/mediawiki/2015/0/0b/DTU-Denmark_hero.jpg)"> |
<div class="igem-logo visible-lg"> | <div class="igem-logo visible-lg"> | ||
<a href="https://igem.org" target="_blank"> | <a href="https://igem.org" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/a/af/DTU-Denmark_igemlogo.png"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 293: | Line 293: | ||
<div class="col-md-4"> | <div class="col-md-4"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/7/7b/DTU-Denmark_cycle.png"> |
</div> | </div> | ||
| Line 347: | Line 347: | ||
<div class="col-md-2 col-md-offset-2"> | <div class="col-md-2 col-md-offset-2"> | ||
<a href="http://www.dtu.dk" target="_blank"> | <a href="http://www.dtu.dk" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/b/b7/DTU-Denmark_dtulogo.png" height="130px"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 363: | Line 363: | ||
<div class="col-md-2"> | <div class="col-md-2"> | ||
<a href="https://igem.org" style="float:left" target="_blank"> | <a href="https://igem.org" style="float:left" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/a/af/DTU-Denmark_igemlogo.png" height="90px"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 374: | Line 374: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://www.lundbeckfonden.com/" target="_blank"> | <a href="http://www.lundbeckfonden.com/" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/e/e2/DTU-Denmark_Lundbeckfonden.jpg"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 380: | Line 380: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://www.ottomoensted.dk" target="_blank"> | <a href="http://www.ottomoensted.dk" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/3/35/DTU-Denmark_Ottomoensted.png"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 386: | Line 386: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://www.novonordiskfonden.dk/en" target="_blank"> | <a href="http://www.novonordiskfonden.dk/en" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/5/5c/DTU-Denmark_NovoNordiskFonden_logo.png"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 392: | Line 392: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="https://dk.vwr.com/" target="_blank"> | <a href="https://dk.vwr.com/" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/e/ea/DTU-Denmark_VWR.jpg"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 398: | Line 398: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://frisenette.dk" target="_blank"> | <a href="http://frisenette.dk" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/c/c8/DTU-Denmark_Frisenette.jpg"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 416: | Line 416: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://us.akg.com/akg-homepage-us.html" target="_blank"> | <a href="http://us.akg.com/akg-homepage-us.html" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/9/9d/DTU-Denmark_AKG.png"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 422: | Line 422: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://www.macrogen.com/" target="_blank"> | <a href="http://www.macrogen.com/" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/1/11/DTU-Denmark_Marcogen.jpg"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 428: | Line 428: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="http://www.snapgene.com/" target="_blank"> | <a href="http://www.snapgene.com/" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/5/58/DTU-Denmark_Snapgene.png"> |
</a> | </a> | ||
</div> | </div> | ||
| Line 434: | Line 434: | ||
<div class="sponsorlogo"> | <div class="sponsorlogo"> | ||
<a href="https://www.neb.com/" target="_blank"> | <a href="https://www.neb.com/" target="_blank"> | ||
| − | <img src="https:// | + | <img src="https://static.igem.org/mediawiki/2015/e/e0/DTU-Denmark_NEB_logo.png"> |
</a> | </a> | ||
</div> | </div> | ||
Revision as of 14:10, 9 November 2015
Project
Introduction
Over the summer we worked with nonribosomal peptide synthetases (NRPSs). We developed a B. subtilis strain capable of oligo-mediated genome engineering and used this strain to alter a NRPS. We also investigated methods of screening for novel products with desired activities.
Background
Nonribosomal peptide synthases (NRPSs) are large multimodular enzymes that synthesize nonribosomal peptides, which are short bioactive peptides with a broad range of functions, including antibiotics, immunosuppressants and anticancer drugs.
MAGE subtilis
Multiplex automated genome engineering (MAGE) utilises cyclical recombination with short oligonucleotides in order to achieve a high allelic replacement efficiency and can be used to quickly generate cell populations with varying phenotypes. We introduced oligo-mediated genome engineering into Bacillus subtilis and used it to alter a nonribosomal peptide synthetase.
Tyrocidine
Tyrocidine is a mixture of non-ribosomal peptides. It can only be used topically due to its toxicity. We sought to express the tyrocidine synthase cluster in B. subtilis to make novel derivatives with oligo-mediated recombineering.
Lab-on-a-disc
Lab-on-a-disc is a potential screening method for our MAGE NRPS products. After screening for antimicrobial activity, prospective MAGE edited NRPS products could be tested for different beneficial properties. One example is a quick screening method for cytotoxicity.
Intein
When one method fails the Synthesizer team has to innovate! We explored an alternative approach for generating short, cyclized peptides with similar length to tyrocidine by using self-splicing proteins. These short, self-splicing proteins that have no function in the proteins they are a part of, besides catalyzing their own excision after translation, are called inteins. The splicing creates a peptide bond between the two adjacent amino acids next to the inteins and we hypothesized that it could be used to make our cyclic peptides.
NRP Detection
Separation and identification of our non-ribosomal peptide synthetase (NRPS) products was determined by ultra-high performance liquid chromatography with diode array detection coupled to quadrupole time-of-flight mass spectrometry (UHPLC-DAD-QTOFMS). NRPS variants were identified by changes in mass-to-charge ratio and column retention time.
